November 2009 Supplement Research Papers

• November 15

  • Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.

    • 2009-11-15
    • International Journal of Food Microbiology 135(3)
    • • N. Salazar
      • P. Ruas-Madiedo
      • S. Kolida
      • M. Collins
      • R. Rastall
      • G. Gibson
      • C. G. de los Reyes-Gavilán

    • PubMed: 19735956
    • DOI: 10.1016/j.ijfoodmicro.2009.08.017

    4 Insights on

    • Improved Gut Microbiota
    • Increased Propionic Acid Levels
    • Increased Atopobium Growth
    • Reduced Butyrate Production

    • Low evidence
    • Highly Cited

  • Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective review

    • 2009-11-15
    • Observational · n = 205
    • European Journal of Clinical Microbiology & Infectious Diseases 29(1)
    • • S. J. Mcbride
      • A. Upton
      • Sally A. Roberts

    • PubMed: 19916034
    • DOI: 10.1007/s10096-009-0830-5

    3 Insights on

    • Increased Mortality Rate
    • Increased Antimicrobial Resistance
    • Moderate High-Level Gentamicin Resistance

    • High evidence
    • Highly Cited
• November 18

  • A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

    • 2009-11-18
    • RCT · n = 61
    • BMC Gastroenterology 9(1)
    • • D. Kalman
      • H. Schwartz
      • Patricia Álvarez
      • S. Feldman
      • J. Pezzullo
      • D. Krieger

    • PubMed: 19922649
    • DOI: 10.1186/1471-230X-9-85

    4 Insights on

    • Reduced Gastrointestinal Symptoms
    • Improved Quality of Life
    • Reduced Abdominal Pain
    • Reduced Abdominal Distension

    • High evidence
    • Highly Cited
    • Rigorous Journal
• Undated – 3 supplement studies

  • Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis.

    • 2009-11
    • American Journal of Physiology-Gastrointestinal and Liver Physiology 297(5)
    • • L. Khailová
      • K. Dvorak
      • Kelly M. Arganbright
      • M. Halpern
      • T. Kinouchi
      • M. Yajima
      • B. Dvořák

    • PubMed: 20501441
    • DOI: 10.1152/AJPGI.00141.2009

    3 Insights on

    • Reduced Pro-Inflammatory Cytokines
    • Improved Intestinal Barrier Integrity
    • Incidence of Necrotizing Enterocolitis

    • Low evidence
    • Highly Cited

  • Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes.

    • 2009-11
    • Journal of applied microbiology 107(5)
    • • S I Yun
      • H O Park
      • J H Kang

    • PubMed: 19457033
    • DOI: 10.1111/j.1365-2672.2009.04350.x

    3 Insights on

    • Improved Glucose Tolerance
    • Reduced Blood Glucose Levels
    • Prevention of Weight Loss

    • Low evidence
    • Highly Cited

  • Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice.

    • 2009-11
    • Clinical Trial
    • International Immunopharmacology 9(12)
    • • Y. Nishitani
      • T. Tanoue
      • Katsushige Yamada
      • T. Ishida
      • Masaru Yoshida
      • T. Azuma
      • M. Mizuno

    • PubMed: 19733697
    • DOI: 10.1016/j.intimp.2009.08.018

    3 Insights on

    • Reduced Inflammatory Markers
    • Reduced Colitis Symptoms
    • Reduced NF-kappaB Nuclear Translocation

    • Low evidence
    • Highly Cited
    • Animal Study